[GnRH analogues containing SV-40 virus T-antigen nuclear localization sequence]

Bioorganicheskaia Khimiia
|November 11, 2010
PubMed

Insights

Researchers synthesized novel GnRH analogues with a nuclear localization signal (NLS) to enhance anticancer drug delivery. These NLS-modified peptides demonstrated significantly increased cytotoxic activity against tumor cells in vitro.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Delivery

Context:

  • Improving the intracellular delivery of anticancer drugs is crucial for enhancing therapeutic efficiency.
  • GnRH (Gonadotropin-releasing hormone) analogues are explored for targeted cancer therapies.
  • Nuclear localization signals (NLS) can facilitate the transport of molecules into the cell nucleus.

Purpose:

  • To synthesize novel GnRH analogues conjugated with the SV-40 virus large T-antigen nuclear localization signal (NLS).
  • To investigate the impact of NLS conjugation on the cytotoxic activity of GnRH analogues, particularly those containing palmitoyl moieties.
  • To evaluate the specificity of the NLS-modified GnRH analogues' action on tumor cells versus normal cells.

Summary:

  • A series of GnRH analogues were synthesized incorporating the SV-40 NLS via D-Lysine residues using orthogonal protection.
  • Biological activity assays demonstrated that the NLS moiety significantly enhanced the in vitro cytotoxic activity of palmitoyl-containing GnRH analogues.
  • Experiments using normal fibroblasts as a control confirmed that the tested peptides' effects on tumor cells did not involve cell membrane destruction.

Impact:

  • This study presents a novel strategy for improving anticancer drug efficacy through targeted intracellular delivery.
  • The development of NLS-conjugated GnRH analogues offers a promising approach for more effective cancer treatment.
  • The findings suggest that NLS modification can enhance the potency of GnRH-based anticancer agents without compromising cell membrane integrity.

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Nuclear Localization Signals and Import01:46

Nuclear Localization Signals and Import

Proteins targeted to the nucleus carry short stretches of amino acid sequences called the nuclear localization signal or NLS. Classical nuclear localization signals are of two types: monopartite and bipartite NLS. Monopartite classical NLS (cNLS) consists of a single cluster of 4-8 amino acids. Bipartite cNLS consists of two clusters of  2-3 amino acids and a 9-12 residue long proline-rich linker bridging the two clusters. Signal clusters are rich in positively charged amino acids such as...